Emprables

Empagliflozin is an oral medication used to manage blood sugar levels in adults with type 2 diabetes. It belongs to a class of drugs known as SGLT2 inhibitors, which help the kidneys remove excess glucose from the body.

Empagliflozin is primarily used to improve glycemic control in adults with type 2 diabetes. It works by increasing the amount of glucose excreted in the urine, thereby lowering blood sugar levels. This medication is often prescribed as part of a comprehensive treatment plan that includes diet and exercise. Empagliflozin may also be used to reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease.

Common effects of Empagliflozin may include increased urination, which is a result of the medication's mechanism of action. Some individuals may also experience symptoms such as thirst, dizziness, or fatigue. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Empagliflozin should be used with caution in individuals with a history of kidney problems, as it can affect kidney function. It is important to stay hydrated while taking this medication to prevent dehydration. Additionally, Empagliflozin may increase the risk of urinary tract infections, so it is important to monitor for symptoms such as pain or burning during urination.

Empagliflozin may interact with certain medications, including diuretics, insulin, and other drugs that lower blood sugar. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated, as it can affect blood sugar levels and increase the risk of dehydration.